2009
DOI: 10.1007/s10616-009-9190-3
|View full text |Cite
|
Sign up to set email alerts
|

CD90 Expression on human primary cells and elimination of contaminating fibroblasts from cell cultures

Abstract: Cluster Differentiation 90 (CD90) is a cell surface glycoprotein originally identified on mouse thymocytes. Although CD90 has been identified on a variety of stem cells and at varying levels in non-lymphoid tissues such as on fibroblasts, brain cells, and activated endothelial cells, the knowledge about the levels of CD90 expression on different cell types, including human primary cells, is limited. The goal of this study was to identify CD90 as a human primary cell biomarker and to develop an efficient and re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
84
1
5

Year Published

2011
2011
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 116 publications
(94 citation statements)
references
References 20 publications
4
84
1
5
Order By: Relevance
“…When selecting for CAF populations using antibody‐based methods such as FACS, it is essential that multiple surface markers are used in order to avoid any chance of introducing unintentional subtype bias. Other available surface markers such as PDGFRα/β work well here, as do more general fibroblast surface markers like Thy‐1 cell surface antigen (CD90), provided that the cell population is also subjected to selection with negative markers . This is especially important, as a significant number of commonly used fibroblast markers display expression over a number of different cell types, running the risk of inadvertent sample contamination if a proper negative selection is not carried out.…”
Section: Resultsmentioning
confidence: 99%
“…When selecting for CAF populations using antibody‐based methods such as FACS, it is essential that multiple surface markers are used in order to avoid any chance of introducing unintentional subtype bias. Other available surface markers such as PDGFRα/β work well here, as do more general fibroblast surface markers like Thy‐1 cell surface antigen (CD90), provided that the cell population is also subjected to selection with negative markers . This is especially important, as a significant number of commonly used fibroblast markers display expression over a number of different cell types, running the risk of inadvertent sample contamination if a proper negative selection is not carried out.…”
Section: Resultsmentioning
confidence: 99%
“…Although these nonmyocyte populations have not been fully characterized, the markers used suggest that they represent a combination of fibroblasts (CD90) 21 , vascular smooth muscle cells (CD140B) 22 and endothelial cells (CD31). Access to enriched populations of each of these cell types together with cardiomyocytes will allow detailed investigation of interactions between them.…”
Section: Discussionmentioning
confidence: 99%
“…To analyse ORFV‐induced effects on the viability of human skin cells, primary human foreskin‐derived KC or FB were infected with the patient‐derived, replication‐competent ORFV isolate B029 or inactivated ORFV (iORFV) and monitored for morphological cellular changes. The purity of the cell preparation was confirmed by flow cytometric analysis of CD45 and CD90 expression (Figure ). Replication‐competent ORFV rapidly induced morphological changes in KC (Figure A).…”
Section: Resultsmentioning
confidence: 97%